K-numberK252217
Device nameCT VScore+
ApplicantCanon Medical Informatics, Inc.
Product codeJAK
Device classClass II
Decision dateNov 28, 2025
DecisionSubstantially Equivalent
Regulation892.1750
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

CT VScore+ is a software application that automatically analyzes ECG-gated, non-contrast cardiac CT images to identify and quantify calcium in the coronary arteries for patients aged 30 and older. It generates Agatston and volume calcium scores for the left main/left anterior descending (LM+LAD), right coronary artery (RCA), and left circumflex (LCX) arteries, with optional comparison to MESA and Hoff-Kondos reference databases. Users can manually edit the automated segmentation results.

Technological characteristics

CT VScore+ uses a proprietary deep learning-based Attention UNet architecture for coronary segmentation, whereas the predicate device (GE CardIQ Suite) uses unspecified deep learning methods. Both devices operate on non-contrast cardiac CT DICOM images, generate Agatston and volume scores, allow user editing of results, and support DICOM Structured Report export. The subject device is more restrictive in scope, analyzing only coronary calcium rather than broader cardiovascular anatomy and pathology.

Test standards cited

Not stated in this summary. The document references FDA-recognized statistical methods and established reference databases (MESA, Hoff-Kondos) but does not cite specific ISO, IEC, or ASTM standards.

Substantial equivalence argument

CT VScore+ is substantially equivalent because it performs the same intended function as the predicate (coronary calcium scoring from non-contrast cardiac CT), uses similar deep learning-based methods with validated performance meeting all acceptance criteria (ICC >0.99 for total scores, Kappa >0.95 for risk classification), and demonstrates no new safety or effectiveness concerns. The subject device includes a subset of predicate functionality with a more restrictive indication, which does not create a new intended use.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →